Precigen Inc (FRA:I5X)
€ 0.8505 0.017 (2.04%) Market Cap: 264.54 Mil Enterprise Value: 252.32 Mil PE Ratio: 0 PB Ratio: 5.71 GF Score: 45/100

Precigen Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 08:40PM GMT
Release Date Price: €7.05 (-1.40%)
Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst

Thanks again for tuning into the JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst. Our next presenting company is Precigen, and it's my pleasure to welcome and introduce President and CEO Helen Sabzevari, to tell us a little bit about the company. (Operator Instructions) Helen, thanks, for sharing some of your time with us this afternoon.

Helen Sabzevari
Precigen, Inc. - President, CEO & Director

Thank you so much, Eric, and thank you for the opportunity to present at the 39th Annual JPMorgan Healthcare Conference. And I also want to -- hope that all of our listeners and their families are safe and healthy as we begin 2021.

Before I start the presentation, I also want to remind everyone, I will be making some forward-looking statements, which please pay attention to the slides that it's in Slide #2. With that in mind, I think we should start and going to Slide #3.

What I really want to touch base today is, first of all, get

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot